Pharmaceutical Technology's In the Lab eNewsletter, October 2023

A Look at Next-Gen Technologies in Adventitious Agent Testing

October 04, 2023

Features

18

10

With advancements in analytical technologies, such as next-generation sequencing, the industry is transitioning towards next-gen technologies for adventitious agent testing.

BenevolentAI Signs Collaboration with Merck

September 26, 2023

News

18

10

BenevolentAI will leverage its suite of AI chemistry design tools in combination with its fully equipped wet lab facility in Cambridge, UK, to deliver small molecule drug development candidates into the Merck pipeline, according to the press release.

Charles River and PathoQuest Publish Study Validating Proprietary Next-Generation Sequencing Viral Safety Assay

September 12, 2023

News

18

10

The results showed that PathoQuest’s proprietary NGS approach is an effective, more robust replacement to in vivo adventitious virus testing of cell substrates used in the production of biologics, like monoclonal antibodies, vaccines, cell, and gene therapies.

Optibrium Acquires BioPharmics

September 07, 2023

News

18

10

Optibrium announced on Aug. 31, 2023 the acquisition of BioPharmics to further expand the 3D drug design and modelling offering and to focus on research and development and application science.